Stay updated on Pembrolizumab for Rare Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a new revision tag, Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new build of the page content without changing the study details themselves.SummaryDifference0.0%

- Check10 days agoChange DetectedA new publication citation by Derbala et al. was added to the study's Publications, documenting AI-guided analysis predicting pembrolizumab response in rare tumors. The page revision was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'), reflecting a change in participant availability. Updated the Interventions label from 'Intervention / Treatment' to 'Intervention/Treatment' and added a new revision (Revision: v3.6.0) while removing the older label (Revision: v3.5.5).SummaryDifference0.4%

- Check31 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4, reflecting a minor metadata update.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing a new build of the page. This indicates an updated version of the page documentation rather than a visible content change.SummaryDifference0.0%

- Check75 days agoChange DetectedUpdated the page’s displayed revision version from v3.5.2 to v3.5.3 as part of the site/system release.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.